Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples